Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Joel, Gabre"'
Autor:
Steven H. Su, Yosuke Mitani, Tianxia Li, Uma Sachdeva, Samuel Flashner, Andres Klein-Szanto, Karen J. Dunbar, Julian Abrams, Hiroshi Nakagawa, Joel Gabre
Publikováno v:
Biomolecules, Vol 14, Iss 9, p 1195 (2024)
Barrett’s esophagus (BE) is a common precancerous lesion that can progress to esophageal adenocarcinoma (EAC). There are significant alterations in the esophageal microbiome in the progression from healthy esophagus to BE to EAC, including an incre
Externí odkaz:
https://doaj.org/article/14eda77af00741c0a2b92619363e21b4
Autor:
Subhradip Mukhopadhyay, Joel Gabre, Christine Chabasse, Jonathan S. Bromberg, Toni M. Antalis, Rajabrata Sarkar
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 5, p 1650 (2020)
Resolution of deep venous thrombosis involves coordinated inflammatory processes. T cells regulate inflammation in vivo and modulate vascular remodeling in other settings, but their role in venous thrombus resolution remains undefined. To determine t
Externí odkaz:
https://doaj.org/article/68c708520ac448d3a78ffde13b2a2128
Autor:
Eric W. Lin, Michele M. Kim, Uma M. Sachdeva, Hiroshi Nakagawa, Maureen DeMarshall, Gary W. Falk, Eric S. Diffenderfer, Anil K. Rustgi, Gregory G. Ginsberg, Jason R. Pitarresi, Tatiana A. Karakasheva, Ricardo Cruz-Acuna, Jinyang Li, Amanda B. Muir, Joel Gabre, Adam J. Bass, Kathryn E. Hamilton, Zhaohai Yang
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Scientific Reports
Scientific Reports
3D patient-derived organoids (PDOs) have been utilized to evaluate potential therapies for patients with different cancers. However, the use of PDOs created from treatment-naive patient biopsies for prediction of clinical outcomes in patients with es
Publikováno v:
Current Treatment Options in Gastroenterology. 18:616-622
To examine the evidence for Familial Barrett’s Esophagus and Esophageal Adenocarcinoma and putative causative genes. Recent large population studies continue to provide evidence for Familial Barrett’s Esophagus and Esophageal Adenocarcinoma. Also
Autor:
Gizem Efe, Qiaosi Tang, Ricardo Cruz-Acuna, Kensuke Suzuki, Kensuke Sugiura, Joel Gabre, Uma Sachdeva, Wei Gu, Carol L. Prives, Anil K. Rustgi
Publikováno v:
Cancer Research. 82:2421-2421
Introduction: Esophageal cancer is a highly aggressive cancer and is the 6th leading cause of cancer mortality worldwide, with esophageal squamous cell carcinoma (ESCC) being the most prevalent subtype. Mutations in the tumor suppressor TP53 (human h
Autor:
Ricardo Cruz-Acuña, Hiroshi Nakagawa, Samuel Flashner, Uma M. Sachdeva, Masataka Shimonosono, Joel Gabre
Publikováno v:
Cancer Lett
Three-dimensional (3D) organoids are a novel tool to model epithelial cell biology and human diseases of the esophagus. 3D organoid culture systems have been utilized to investigate the pathobiology of esophageal cancer, including both squamous cell
Publikováno v:
Digestive Diseases and Sciences
Publikováno v:
Digestive Diseases and Sciences
Autor:
Joel Gabre, Jianwen Que, Angela J. Yoon, Ricardo Cruz-Acuna, Gary W. Falk, Shoji Natsugoe, Adam J. Bass, Julian A. Abrams, Tatiana A. Karakasheva, Lorenzo Ferri, Veena Sangwan, Anil K. Rustgi, Timothy C. Wang, Hiroshi Nakagawa, Varun Sahu, Kelly A. Whelan, Gregory G. Ginsberg, Elizabeth Philipone, J. Alan Diehl, Veronique Giroux, Hisatsugu Maekawa, Andres J. Klein-Szanto, Devraj Basu, Masataka Shimonosono, Takashi Kijima
Publikováno v:
Curr Protoc Stem Cell Biol
Esophageal cancers comprise adenocarcinoma and squamous cell carcinoma, two distinct histologic subtypes. Both are difficult to treat and among the deadliest human malignancies. We describe protocols to initiate, grow, passage, and characterize patie
Autor:
Christine Chabasse, Subhradip Mukhopadhyay, Rajabrata Sarkar, Toni M. Antalis, Joel Gabre, Jonathan S. Bromberg
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 5, p 1650 (2020)
International Journal of Molecular Sciences
Volume 21
Issue 5
International Journal of Molecular Sciences
Volume 21
Issue 5
Resolution of deep venous thrombosis involves coordinated inflammatory processes. T cells regulate inflammation in vivo and modulate vascular remodeling in other settings, but their role in venous thrombus resolution remains undefined. To determine t